116 related articles for article (PubMed ID: 38387911)
1. [Effect of Chlorambucil Combined with Ibrutinib on Mantle Cell Lymphoma Cell Line Jeko-1 and Its Related Mechanism].
Cai NN; Liu WY; Liu ZQ; Gong JH; Lin YL; Wang ZC; Huang YQ; Guo JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):132-137. PubMed ID: 38387911
[TBL] [Abstract][Full Text] [Related]
2. [Action Mechanism of Chlorambucil against Mantle Cell Lymphoma Cell Line Jeko-1].
Guo JX; Zhou YH; Pan JX; Guo XZ; Wu SX; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1066-70. PubMed ID: 27531776
[TBL] [Abstract][Full Text] [Related]
3. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Decitabine Combined with Bortezomib on the Proliferation of Mantle Cell Lymphoma Cell Lines and Its Underling Mechanisms].
Zhang JN; Qiao SK; Chen D; Xing LN; Li Y; Guo XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1197-1204. PubMed ID: 32798398
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Sinomenine on Proliferation and Apoptosis of MCL Jeko-1 Cell Line and Its Mechanism].
Chen SY; Zou Y; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1675-1679. PubMed ID: 29262896
[TBL] [Abstract][Full Text] [Related]
6. [Effect of midazolam on mantle cell lymphoma JeKo-1 cell line and its relevant mechanisms].
Hong JQ; Wu SH; Chen ZY; Zhuang WH; Gao HZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1460-3. PubMed ID: 24370029
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of PI3K and BCL-2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma.
Ye H; Huang S; Liu Y; Chen Z; Wang M; Jiang VC
J Cell Mol Med; 2022 May; 26(10):3068-3073. PubMed ID: 35352453
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Silencing AKT Gene by shRNA on Proliferation, Apoptosis and Notch1 Signal Pathway in Jeko-1 Cells].
Zhu B; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):679-83. PubMed ID: 26117016
[TBL] [Abstract][Full Text] [Related]
9. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.
Sun B; Shah B; Fiskus W; Qi J; Rajapakshe K; Coarfa C; Li L; Devaraj SG; Sharma S; Zhang L; Wang ML; Saenz DT; Krieger S; Bradner JE; Bhalla KN
Blood; 2015 Sep; 126(13):1565-74. PubMed ID: 26254443
[TBL] [Abstract][Full Text] [Related]
11. Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosis.
Cinar M; Hamedani F; Mo Z; Cinar B; Amin HM; Alkan S
Leuk Res; 2013 Oct; 37(10):1271-7. PubMed ID: 23962569
[TBL] [Abstract][Full Text] [Related]
12. Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma.
Liu Z; Liu J; Zhang T; Li L; Zhang S; Jia H; Xia Y; Shi M; Zhang J; Yue S; Chen X; Yu J
BMC Cancer; 2021 Jun; 21(1):732. PubMed ID: 34174847
[TBL] [Abstract][Full Text] [Related]
13. Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma.
Yan X; Zhou Y; Huang S; Li X; Yu M; Huang J; Wang J; Ma Z; Jin J; Pan J; Li C; Li F; Jin J
J Cancer Res Clin Oncol; 2018 Apr; 144(4):697-706. PubMed ID: 29392403
[TBL] [Abstract][Full Text] [Related]
14. [Antiproliferative Effect of Specific Inhibitor XAV939 for β-catenin on MCL Jeko-1 Cells].
He JS; Huang YQ; Weng JM; Xiao LY; Weng KZ; Ma XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):411-5. PubMed ID: 25948195
[TBL] [Abstract][Full Text] [Related]
15. MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.
Wu X; Nowakowski KE; Abeykoon JP; Manske M; Stenson MJ; Timm MM; Hanson CA; Van Dyke DL; Dasari S; Witzig TE
Eur J Haematol; 2021 Oct; 107(4):458-465. PubMed ID: 34214199
[TBL] [Abstract][Full Text] [Related]
16. [The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph
Wu JH; Shi FF; Gong YP; Shi R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):216-220. PubMed ID: 28612529
[TBL] [Abstract][Full Text] [Related]
17. [Effects of 13-cis-retinoic acid combined with interferon-α2b in mantle cell lymphoma cell lines (Jeko-1)
Liu ZB; Wen JJ; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):50-54. PubMed ID: 28219226
[No Abstract] [Full Text] [Related]
18. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway.
Zhang Y; Lu P; Zhou Y; Zhang L
PeerJ; 2021; 9():e12571. PubMed ID: 35003920
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of Autophagy Augments the Anticancer Activity of KPT-330 in Mantle Cell Lymphoma Cells].
Zhang YL; Chen YH; Zheng RJ; Zheng KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):470-475. PubMed ID: 38660854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
